EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenol–Croton Oil Application in the Treatment of Xanthelasma Palpebrarum

Gulsen Akoglu iD, Ahmet Tecik iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Gulsen Akoglu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatovenereology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Phenol, Croton Oil, Xanthomatosis, Eyelid Diseases. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xanthelasma palpebrarum (XP) can cause significant cosmetic problems, and no standard treatment approach exists.

Aim

To evaluate the outcomes of phenol–croton oil application in XP.

Method

The medical files and photographs of 10 patients treated with the topical application of 60% phenol and 1% croton oil solution (PCO) were retrospectively analyzed. Demographic and clinical features of the patients, XP severity, extent of XP lesions, and treatment outcomes were reviewed. The cosmetic outcomes were evaluated with the physician's and patient's visual analog scale (VAS) scores (from 1 to 6), and adverse effects and patient comments about the procedure were reviewed from the records.

Results

The study included five males and five females with a range of 30–62 years of age. The XP severity score ranged between 5 and 10, and 60% of patients had severe disease. Nine patients (90%) benefited from the treatment; six (60%) were cured, and more than 60% improvement was observed in three patients after one to three sessions of PCO application. Postprocedural erythema occurred in three patients and faded in time. Postinflammatory hypopigmentation was observed in four patients and was hardly noticeable in follow‐ups. Most patients expressed their impression of the cosmetic outcome as a VAS score of 5 or more. Except for one who was unhappy with the dyspigmentation, all patients stated that they would recommend the procedure to other patients with XP seeking treatment.

Conclusion

Topical PCO application on XP lesions is a safe, easily applicable, and cost‐effective treatment option requiring few sessions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenolCroton OilXanthomatosisEyelid DiseasesHumansAdultFemaleMaleRetrospective StudiesMiddle AgedTreatment OutcomeSeverity of Illness IndexPatient SatisfactionAdministration, Cutaneous

Stichwörter der Autor:innen

phenoltreatmentxanthelasma palpebrarum

Substanzen

PhenolCroton Oil

Autor:innen und Institutionen

  • Department of Dermatovenereology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Türkiye.

ORCID-Profile: Gulsen Akoglu, Ahmet Tecik

Zitieren

APA

Akoglu, G., & Tecik, A. (2025). Phenol–Croton Oil Application in the Treatment of Xanthelasma Palpebrarum. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70551

Vancouver

Akoglu G, Tecik A. Phenol–Croton Oil Application in the Treatment of Xanthelasma Palpebrarum. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70551

BibTeX
@article{Akoglu2025,
  author = {Akoglu, Gulsen and Tecik, Ahmet},
  title = {Phenol–Croton Oil Application in the Treatment of Xanthelasma Palpebrarum},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70551}
}
Kostenlos starten →